Legend Biotech (LEGN) Misses Q1 EPS by 16c

Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.15), $0.16 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $305.1 million versus the consensus estimate of $305.88 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MagnaChip (MX) files $50M mixed shelf
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders